Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAESAR: Sacubitril/Valsartan vs Ramipril in ADHF with CKD
NCT07023016Phase 3Completed
- Start
- Nov 2023
- Primary completion
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sacubitril + valsartan in heart failure (HF). Started Nov 2023; status: completed.
02
Drugs
sacubitril + valsartan
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT07023016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07023016.